David Geffen School of Medicine at UCLA(Harbor-UCLA Medical Center)

Los Angeles, California 90095

0 studies enrolling now · 1 studies all time

What they study most

Idiopathic Pulmonary Fibrosis

Studies at this site

• (ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF — Stopped early